Abstract
Rationale
NKP608, a selective NK1 receptor antagonist, has been shown to produce anxiolytic-like effects in rodents tested in different anxiety models. However, most of these findings are based on social behaviors and, to our knowledge, there is no report concerning the effects of NKP608 in the elevated plus-maze (EPM) and the open field (OF), two classical models of anxiety/emotionality. Moreover, this compound has never been tested in rodent strains that display contrasting levels of anxiety-related behaviors.
Objectives
To investigate the anxiolytic-like effects of NKP608 in Lewis and SHR inbred rats, proposed as a genetic model of anxiety for showing high and low indices of anxiety, respectively.
Methods
Lewis and SHR rats of both sexes were tested in the EPM and OF tests following acute administration of NKP608 (0.003, 0.03 or 0.3Â mg/kg) or chlordiazepoxide (CDZ, 5Â mg/kg). Measures of approach/avoidance towards the open arms of the EPM and the central area of the OF were used as indices of anxiety.
Results
All doses of NKP608 produced anxiolytic-like effects, similar to those of CDZ, in SHR males tested in the OF but not in the EPM. Conversely, this compound had a partial anxiolytic effect in LEW males (and, to a lower degree, in SHR females) in the EPM, but not in the OF. LEW females were unaffected following all pharmacological treatments.
Conclusions
These findings indicate that the anxiety-related effects of NKP608 are strain-, sex- and test-dependent. Moreover, the present data confirm and extend the therapeutic potential of NK1 receptor antagonists for the treatment of anxiety.
Similar content being viewed by others
References
Aguiar MS, Brandão ML (1996) Effects of microinjections of the neuropeptide substance P in the dorsal periaqueductal gray on the behavior of rats in the plus-maze test. Physiol Behav 60:1183–1186
Angrini M, Leslie JC, Shephard RA (1998) Effects of propanolol, buspirone, pCPA, reserpine, and chlordiazepoxide on open-field behavior. Pharmacol Biochem Behav 59:387–397
Bilkei-Gorzo A, Racz I, Michel K, Zimmer A (2002) Diminished anxiety- and depression-related behaviors in mice with selective deletion of the Tac1 gene. J Neurosci 22:10046–10052
Boyce S, Smith D, Carlson E, Hewson L, Rigby M, O`Donnel R, Harrison T, Rupniak NMJ (2001) Intra-amygdala injection of the substance P (NK1 receptor) antagonist L-760735 inhibits neonatal vocalisations in guinea-pigs. Neuropharmacology 41:130–137
Cheeta S, Tucci S, Sandhu J, Williams AR, Rupniak NMJ, File SE (2001) Anxiolytic actions of the substance P (NK1) receptor antagonist L-760735 and the 5-HT1A agonist 8-OH-DPAT in the social interaction test in gerbils. Brain Res 915:170–175
De Lima TC, Ribeiro SJ (1996) Central effects of tachykinin NK receptor agonists and antagonists on the elevated plus-maze behavior in rats. Soc Neurosci Abstr 22:1154
File SE (1997) Anxiolytic action of a neurokinin1 receptor antagonist in the social interaction test. Pharmacol Biochem Behav 58:747–752
File SE (2000) NKP608, an NK1 receptor antagonist, has an anxiolytic action in the social interaction test in rats. Psychopharmacology 152:105–109
Fink G, Sumner BE, Rosie R, Grace O, Quinn JP (1996) Estrogen control of central neurotransmission: effect on mood, mental state, and memory. Cell Mol Neurobiol 16:325–344
Fischer CE, Hughes RN (1996) Effects of diazepam and cyclohexyladenosine on open-field behavior in rats perinatally exposed to caffeine. Life Sci 58:701–709
Gavioli EC, Canteras NS, De Lima TCM (1999) Anxiogenic-like effect induced by substance P injected into the lateral septal nucleus. Neuroreport 10:3399–3403
Gentsch C, Cutler M, Vassout A, Veenstra S, Brugger F (2002) Anxiolytic effect of NKP608, a NK1-receptor antagonist, in the social investigation test in gerbils. Behav Brain Res 133:363–368
Godfroid IO (1999) Sex differences relating to psychiatric treatment. Can J Psychiatry 44:362–367
Gray JA, Flint J, Dawson GR, Fulker DW (1999) A Strategy to home-in on polygenes influencing susceptibility to anxiety. Hum Psychopharmacol Clin Exp 14:S3–S10
Gyertyán I (1992) Animal models of anxiety: a critical review. Acta Physiol Hungarica 79:369–379
Hall CS (1934) Emotional behavior in the rat. I., Defecation and urination as measures of individual differences in emotionality. J Comp Psychol 18:385–403
Hall CS (1936) Emotional behavior in the rat. III The relationship between emotionality and ambulatory activity. J Comp Psychol 22:345–452
Handley SL, McBlane JW (1993) An assessment of the elevated X-maze for studying anxiety and anxiety-modulating drugs. J Pharmacol Toxicol Meth 29:129–138
Hasenöhrl RU, Jentjens O, Silva AS, Tomaz C, Huston JP (1998) Anxiolytic-like action of neurokinin substance P administered systemically or into the nucleus basalis magnocellularis region. Eur J Pharmacol 354:123–133
Hogg SA (1996) Review of the validity and variability of the elevated plus-maze as an animal model of anxiety. Pharmacol Biochem Behav 54:21–30
Kramer MS, Cutler N, Feighner J, Shrivastava R, Carman J, Stramek JJ, Reines SA, Liu G, Snavely D, Wyatt-Knowles E, Hale JJ, Mills SG, MacCoss M, Swain CJ, Harrison T, Hill RG, Hefti F, Scolnick EM, Cascieri MA, Chicchi GG, Sadowski S, Williams AR, Hewson L, Smith D, Carlson EJ, Hargreaves RJ, Rupniak NMJ (1998) Distinct mechanism for antidepressant activity by blockade of central substance P receptors. Science 281:1640–1645
Lesch KP (2001) Molecular foundation of anxiety disorders. J Neural Transm 108:717–746
Montgomery KC (1955) The relation between fear induced by novel stimulation and exploratory behavior. J Comp Physiol Psychol 48:254–260
Otsuka M, Yoshioka K (1993) Neurotransmitter functions of mammalian tachykinins. Physiol Rev 73:229–308
Papp M, Vassout A, Gentsch C (2000) The NK1-receptor antagonist NKP608 has an antidepressant-like effect in the chronic mild stress model of depression in rats. Behav Brain Res 115:19–23
Pellow S, Chopin P, File SE, Briley M (1985) Validation of open, closed arms entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Meth 14:149–167
Prut L, Belzung C (2003) The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review. Eur J Pharmacol 463:3–33
Ramos A, Mormède P (1998) Stress and emotionality: a multidimensional and genetic approach. Neurosci Biobehav Rev 22:33–57
Ramos A, Berton O, Mormède P, Chaouloff F (1997) A multiple-test study of anxiety-related behaviors in six inbred rat strains. Behav Brain Res 85:57–69
Ramos A, Mellerin Y, Mormède P, Chaouloff F (1998) A genetic and multifactorial analysis of anxiety-related behaviours in Lewis and SHR intercrosses. Behav Brain Res 96:195–205
Ramos A, Moisan M-P, Chaouloff F, Mormède C, Mormède P (1999) Identification of female-specific QTLs affecting an emotionality-related behavior in rats. Mol Psychiatry 4:453–462
Ramos A, Kangerski AL, Basso PF, Da Silva Santos JE, Assreuy J, Vendruscolo LF, Takahashi RN (2002) Evaluation of Lewis and SHR rat strain as a genetic model for the study of anxiety and pain. Behav Brain Res 129:113–123
Ribeiro-da-Silva A, Hökfelt T (2000) Neuroanatomical localisation of substance P in the CNS and sensory neurons. Neuropeptides 34:256–271
Rupniak NMJ, Carlson EC, Harrison T, Oates B, Seward E, Owen S, Felipe C, Hunt S, Wheeldon A (2000) Pharmacological blockade or genetic deletion of substance P (NK1) receptors attenuates neonatal vocalization in guinea-pigs and mice. Neuropharmacology 39:1413–1421
Santarelli L, Gobbi G, Debs PC, Sibille EL, Blier P, Hen R, Heath MJS (2001) Genetic and pharmacological disruption of neurokinin1 receptor function decrease anxiety-related behaviors and increases serotonergic function. Proc Natl Acad Sci USA 98:1912–1917
Spooren WPJM, Schoeffter P, Gasparini F, Kuhn R, Gentsch C (2002) Pharmacological and endocrinological characterization of stress-induced hyperthermia in single housed mice using classical and candidate anxiolytics (LY314582, MPEP and NKP608). Eur J Pharmacol 435:161–170
Stout SC, Owens MJ, Nemeroff CB (2001) Neurokinin 1 receptor antagonists as potential antidepressants. Annu Rev Pharmacol Toxicol 41:877–906
Teixeira RM, Santos ARS, Ribeiro SJ, Calixto JB, Rae GA, De Lima TCM (1996) Effects of central administration of tachykinin receptor agonists and antagonists on plus-maze behavior in mice. Eur J Pharmacol 311:7–14
Treit D, Menard J, Royan C (1993) Anxiogenic stimuli in the elevated plus-maze. Pharmacol Biochem Behav 44:463–469
van de Wetering BJM, van den Heuvel OA, Pauls DL (1999) The genetics of anxiety disorders. Acta Neuropsychiatr 11:63–66
Varty GB, Cohen-Williams ME, Morgan CA, Pylak U, Duff RA, Lachowicz JE, Carey GJ, Coffin VL (2002) The gerbil elevated plus-maze II: Anxiolytic-like effects of selective neurokinin NK1 receptor antagonists. Neuropsychopharmacology 27:357–370
Vassout A, Veenstra S, Hauser K, Ofner S, Brugger F, Schilling W, Gentsch C (2000) NKP608: a selective NK-1 receptor antagonist with anxiolytic-like effects in the social interaction and social exploration test in rats. Reg Pept 96:7–16
Acknowledgements
We wish to thank Dr. Conrad Gentsch from Pharma Novartis in Basel for providing to us NKP608. A. Ramos and R.N. Takahashi had fellowships from CNPq. L.F. Vendruscolo had a scholarship from CAPES. G.R. Brüske had a scholarship from PIBIC-CNPq.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Vendruscolo, L.F., Takahashi, R.N., Brüske, G.R. et al. Evaluation of the anxiolytic-like effect of NKP608, a NK1-receptor antagonist, in two rat strains that differ in anxiety-related behaviors. Psychopharmacology 170, 287–293 (2003). https://doi.org/10.1007/s00213-003-1545-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00213-003-1545-4